3 hours ago
1
hapabapa/iStock Editorial via Getty Images
Update: Adds company confirmation and Pfizer's response.
Metsera (MTSR) has confirmed receipt of an unsolicited buyout proposal from Novo Nordisk (NVO), declaring the bid as a “superior” offer.
Novo Nordisk’s offer values Metsera at up to $77.75 a share, a total of ~$9
English (US) ·